The impact of China's zero markup drug policy on drug costs for managing Parkinson's disease and its complications: an interrupted time series analysis

BACKGROUND: In April 2009, the Chinese government launched Zero Markup Drug Policy (ZMDP) to adjust medical institutions' revenue and expenditure structures. OBJECTIVE: This study evaluated the impact of implementing ZMDP (as an intervention) on the drug costs for managing Parkinson's dise...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ruilin, Li, Xinya, Gu, Xinchun, Cai, Qian, Wang, Yayong, Yi, Zhan-Miao, Chen, Li-Chia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Public Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10203530/
https://www.ncbi.nlm.nih.gov/pubmed/37228740
http://dx.doi.org/10.3389/fpubh.2023.1159119

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10203530/
https://www.ncbi.nlm.nih.gov/pubmed/37228740
http://dx.doi.org/10.3389/fpubh.2023.1159119

Ejemplares similares